Aun Consulting
2459
Welby
4438
Value Creation
9238
Perseus Proteomics
4882
DMS
9782
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -6,455.87%-13.54B | -170.47%-11.14B | -371.71%-12.21B | -98.35%213M | -42.26%15.81B | 4.67B | -298.38%-6.24B | -28.60%4.49B | 45.11%12.88B | -75.14%27.38B |
Net profit before non-cash adjustment | -56.79%3.33B | 15.83%29.33B | 0.14%8.32B | 13.63%7.71B | 22.39%25.32B | --5.07B | 35.82%5.16B | 84.76%8.31B | 3.41%6.79B | -29.49%20.69B |
Total adjustment of non-cash items | -2,991.05%-5.87B | -220.03%-929M | -4,461.54%-567M | -47.29%-190M | -14.57%774M | --211M | 8.64%679M | 107.83%13M | 50.76%-129M | 1,015.15%906M |
-Depreciation and amortization | 7.38%160M | 8.10%587M | 13.18%146M | 29.57%149M | 11.04%543M | --153M | 21.67%146M | 7.50%129M | -8.00%115M | 18.12%489M |
-Reversal of impairment losses recognized in profit and loss | ---- | --106M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
-Share of associates | 25.00%5M | -840.28%-677M | -2,063.89%-707M | 103.67%4M | 81.49%-72M | ---5M | 109.09%6M | -59.09%36M | 74.53%-109M | -204.29%-389M |
-Disposal profit | ---28M | -51.22%40M | --0 | --0 | -31.09%82M | --82M | --0 | --0 | --0 | 156.67%119M |
-Net exchange gains and losses | -575.00%-27M | -362.50%-37M | 66.67%-4M | -116.67%-4M | 97.00%-8M | ---2M | 83.49%-18M | 86.81%-12M | 158.54%24M | -385.45%-267M |
-Remuneration paid in stock | -11.11%8M | -10.53%34M | -10.00%9M | 12.50%9M | 8.57%38M | --10M | 11.11%10M | 11.11%10M | -11.11%8M | -85.60%35M |
-Other non-cash items | -1,621.55%-5.99B | -614.14%-982M | 92.67%-11M | -108.38%-348M | -79.22%191M | ---27M | -20.27%535M | 63.50%-150M | -328.77%-167M | 206.37%919M |
Changes in working capital | -50.46%-10.99B | -284.33%-39.54B | -421.94%-19.96B | -217.51%-7.31B | -277.98%-10.29B | ---608M | -840.26%-12.07B | -295.00%-3.82B | 141.57%6.22B | -92.85%5.78B |
-Change in receivables | 1,017.31%1.16B | -167.80%-1.27B | -3,394.44%-629M | -94.88%104M | 197.91%1.88B | ---1M | 76.58%-137M | 93.81%-18M | 1,872.82%2.03B | -2,654.67%-1.92B |
-Change in inventory | -340.33%-7.2B | -132.68%-35.23B | -261.46%-21.96B | -138.24%-1.63B | -344.04%-15.14B | ---6.55B | -224.99%-6.79B | -46,823.08%-6.07B | -8.29%4.27B | -92.86%6.2B |
-Change in payables | -18.31%-6.48B | -139.40%-1.78B | 9.38%3.07B | -14,133.33%-5.47B | 135.02%4.51B | --6.65B | -1,003.08%-4.99B | 21.34%2.8B | 101.89%39M | 262.21%1.92B |
-Provision for loans, leases and other losses | -213.58%-254M | 400.00%120M | 11.34%108M | 26.36%-81M | -214.29%-40M | ---128M | 17.44%101M | -38.22%97M | 17.91%-110M | -61.54%35M |
-Changes in other current assets | 892.83%1.77B | 7.64%-1.38B | 13.13%-549M | -1,293.75%-223M | -223.16%-1.49B | ---582M | -134.97%-263M | -177.19%-632M | -245.45%-16M | 90.84%-462M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -149.56%-282M | -27.76%-649M | -12.90%-140M | 17.52%-113M | 20.13%-508M | -117M | 16.13%-130M | 22.01%-124M | 20.81%-137M | 14.75%-636M |
Interest received (cash flow from operating activities) | -50.00%1M | -86.36%9M | -95.24%2M | 100.00%2M | -75.74%66M | 3M | 1,900.00%20M | -84.27%42M | 0.00%1M | 4,433.33%272M |
Tax refund paid | -2.76%-4.76B | -128.83%-8.14B | -79.17%5M | -282.18%-4.63B | 50.18%-3.56B | -1M | 33.28%-2.37B | 166.67%24M | 65.89%-1.21B | 35.58%-7.14B |
Other operating cash inflow (outflow) | -1M | 0 | 0 | 0 | 0 | 0 | 200.00%1M | -200.00%-1M | 0 | 0.00%-1M |
Operating cash flow | -310.15%-18.58B | -268.62%-19.91B | -378.33%-12.34B | -139.29%-4.53B | -40.58%11.81B | --4.56B | -1,460.93%-8.71B | -30.35%4.43B | 123.95%11.53B | -79.78%19.88B |
Investing cash flow | ||||||||||
Capital expenditures | ---415M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net PPE purchase and sale | --100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net business purchase and sale | ---- | -31,260.00%-3.12B | ---- | ---- | -37.50%10M | --10M | --0 | ---- | ---- | --16M |
Net investment product transactions | 21,700.00%216M | 2,133.33%61M | --121M | 0.00%-1M | 57.14%-3M | ---1M | ---1M | --0 | 80.00%-1M | -250.00%-7M |
Advance cash and loans provided to other parties | ---- | 98.23%-4M | ---- | ---- | -10.24%-226M | --0 | --0 | ---- | ---- | 76.30%-205M |
Net changes in other investments | 99.61%-4M | 23.78%-3.34B | 62.97%-784M | -346.12%-1.04B | -253.68%-4.39B | ---1.37B | -11.74%-666M | -1,350.00%-2.12B | -106.96%-232M | 293.11%2.85B |
Investing cash flow | 90.06%-103M | -39.02%-6.4B | -30.09%-3.05B | -344.64%-1.04B | -273.25%-4.61B | ---1.36B | -11.91%-667M | -1,702.31%-2.34B | -107.46%-233M | 1,985.11%2.66B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 358.87%8.91B | 1,316.67%19.86B | 1,126.11%18.5B | 41.66%-3.44B | 89.86%-1.63B | ---2.38B | 200.74%5.14B | 169.03%1.51B | 7.41%-5.9B | 71.02%-16.1B |
Net common stock issuance | --0 | 0.38%527M | --0 | 875.00%78M | -20.93%525M | --449M | -53.15%52M | -95.64%16M | -95.70%8M | -87.02%664M |
Cash dividends paid | -14.75%-1.66B | -11.12%-2.9B | 16.67%-5M | -11.25%-1.44B | -19.08%-2.61B | ---2M | -18.78%-1.3B | -20.00%-6M | -19.41%-1.3B | -30.34%-2.19B |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---210M |
Net other fund-raising expenses | 300.00%2M | -300.00%-2M | --0 | 0.00%-1M | 100.08%1M | ---- | ---- | ---- | 99.91%-1M | -13,033.33%-1.18B |
Financing cash flow | 250.89%7.26B | 570.58%17.48B | 1,116.91%18.5B | 33.13%-4.81B | 80.46%-3.72B | ---1.93B | 163.77%3.89B | 177.71%1.52B | 15.60%-7.19B | 63.51%-19.01B |
Net cash flow | ||||||||||
Beginning cash position | -8.26%98.1B | 3.37%106.93B | -10.22%96.56B | 3.37%106.93B | 3.52%103.44B | --105.67B | 6.93%111.16B | 7.90%107.54B | 3.52%103.44B | 139.71%99.92B |
Current changes in cash | -10.11%-11.43B | -353.12%-8.83B | -13.93%3.11B | -352.89%-10.38B | -0.82%3.49B | --1.26B | 24.39%-5.49B | -15.63%3.61B | 1,728.17%4.1B | -92.35%3.52B |
Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%2M | ---2M | 0.00%1M |
Cash adjustments other than cash changes | 0.00%-1M | 0.00%-1M | ---- | 0.00%-1M | -200.00%-1M | ---- | ---- | --0 | -150.00%-1M | 200.00%1M |
End cash Position | -10.24%86.67B | -8.26%98.1B | -10.34%99.66B | -10.22%96.56B | 3.37%106.93B | --106.93B | 9.28%105.67B | 6.93%111.16B | 7.90%107.54B | 17.94%103.44B |
Free cash flow | -319.32%-19B | -268.62%-19.91B | -378.33%-12.34B | -139.29%-4.53B | -40.58%11.81B | --4.56B | -1,460.93%-8.71B | -30.35%4.43B | 123.95%11.53B | -79.78%19.88B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |